3 results
Approved WMOCompleted
Primary * To evaluate the efficacy of SAR245409 as determined by the objective response rate (ORR) in patients with 1 of the following relapsed or refractory lymphoma or leukemia subtypes: mantle cell lymphoma (MCL), follicular lymphoma (FL), or…
Approved WMOCompleted
To evaluate the safety and initial feasibility of PEF treatment of NSCLC tumors prior to surgical resection.
Approved WMOCompleted
To evaluate the safety and clinical utility of PEF treatment of advanced stage or metastatic cancer following progression on immunotherapy